‪J. Joshua Smith, M.D., Ph.D., F.A.C.S.‬

Cytowane przez

	Wszystkie	Od 2020
Cytowania	16318	11615
h-indeks	55	44
i10-indeks	166	115

3100

1550

775

2325

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202546 52 58 57 59 59 79 100 149 205 289 320 334 398 453 536 882 1158 1663 2305 2901 3062 480

Dostęp publiczny

Wyświetl wszystko

136 artykułów

4 artykuły

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Mithat GönenMemorial Sloan-Kettering Cancer CenterZweryfikowany adres z alumni.stanford.edu
Xi (Steven) ChenProfessor of Biostatistics, University of MiamiZweryfikowany adres z miami.edu
Andrea CercekMSKCCZweryfikowany adres z mskcc.org
R. Daniel BeauchampProfessor of Surgery, Vanderbilt UniversityZweryfikowany adres z vanderbilt.edu
Rona YaegerMemorial Sloan Kettering Cancer CenterZweryfikowany adres z mskcc.org
Martin R WeiserMemorial Sloan Kettering Cancer CenterZweryfikowany adres z mskcc.org
Efsevia Vakiani MD PhDAssistant Attending, Memorial Sloan Kettering Cancer Center, New York, USAZweryfikowany adres z mskcc.org
zsofia stadlerAssociate Attending Physician, Memorial Sloan KetteringZweryfikowany adres z mskcc.org
Neil H. SegalMSKCCZweryfikowany adres z mskcc.org
Abraham WuAssociate Attending, Memorial Sloan Kettering Cancer CenterZweryfikowany adres z mskcc.org
Steven EschrichMoffitt Cancer CenterZweryfikowany adres z moffitt.org
Sujata PatilCleveland ClinicZweryfikowany adres z ccf.org
Ronald DeMatteoZweryfikowany adres z uphs.upenn.edu
Campbell RoxburghUniversity Department of Surgery, Glasgow Royal InfirmaryZweryfikowany adres z glasgow.ac.uk
Christopher S. Williams, MD/PhDAssociate Dean, Professor of Gastroenterology & Cancer Biology Vanderbilt University MedicalZweryfikowany adres z vanderbilt.edu
Keith T. WilsonProfessor of Medicine, Vanderbilt University Medical CenterZweryfikowany adres z vumc.org
Professor Paris TekkisImperial College London, The Royal Marsden Hospital, Chelsea & Westminster HospitalZweryfikowany adres z imperial.ac.uk
Tsuyoshi KonishiThe University of Texas M.D. Anderson Cancer CenterZweryfikowany adres z umin.ac.jp
Raphael PelossofTempus LabsZweryfikowany adres z tempus.com
Isaac WassermanMassachusetts Eye & Ear Infirmary / HarvardZweryfikowany adres z meei.harvard.edu

Obserwuj

J. Joshua Smith, M.D., Ph.D., F.A.C.S.

Memorial Sloan Kettering Cancer Center | Colorectal Service | Dept of Surgery | Assoc. Member

Zweryfikowany adres z mskcc.org - Strona główna

Rectal Cancer Colon Cancer Organ Preservation Translational Research Surgical Oncology


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Nomograms in oncology: more than meets the eye VP Balachandran, M Gonen, JJ Smith, RP DeMatteo The lancet oncology 16 (4), e173-e180, 2015	2715	2015
PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer A Cercek, M Lumish, J Sinopoli, J Weiss, J Shia, M Lamendola-Essel, ... New England Journal of Medicine 386 (25), 2363-2376, 2022	1133	2022
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer JJ Smith, NG Deane, F Wu, NB Merchant, B Zhang, A Jiang, P Lu, ... Gastroenterology 138 (3), 958-968, 2010	716	2010
Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ... Journal of clinical oncology 40 (23), 2546-2556, 2022	616	2022
Adoption of total neoadjuvant therapy for locally advanced rectal cancer A Cercek, CSD Roxburgh, P Strombom, JJ Smith, LKF Temple, GM Nash, ... JAMA oncology 4 (6), e180071-e180071, 2018	579	2018
Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy JJ Smith, P Strombom, OS Chow, CS Roxburgh, P Lynn, A Eaton, ... JAMA oncology 5 (4), e185896-e185896, 2019	525	2019
A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019	449	2019
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer … JJ Smith, OS Chow, MJ Gollub, GM Nash, LK Temple, MR Weiser, ... BMC cancer 15, 1-13, 2015	378	2015
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors C Valero, M Lee, D Hoen, K Weiss, DW Kelly, PS Adusumilli, PK Paik, ... Nature communications 12 (1), 729, 2021	328	2021
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance JM Balko, RS Cook, DB Vaught, MG Kuba, TW Miller, NE Bhola, ... Nature medicine 18 (7), 1052-1059, 2012	322	2012
Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome T Konishi, Y Shimada, M Hsu, L Tufts, R Jimenez-Rodriguez, A Cercek, ... JAMA oncology 4 (3), 309-315, 2018	267	2018
Advances and challenges in treatment of locally advanced rectal cancer JJ Smith, J Garcia-Aguilar Journal of clinical oncology 33 (16), 1797-1808, 2015	220	2015
The association between tumor mutational burden and prognosis is dependent on treatment context C Valero, M Lee, D Hoen, J Wang, Z Nadeem, N Patel, MA Postow, ... Nature genetics 53 (1), 11-15, 2021	211	2021
Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin TJ Freeman, JJ Smith, X Chen, MK Washington, JT Roland, AL Means, ... Gastroenterology 142 (3), 562-571. e2, 2012	209	2012
Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma CW Barrett, W Ning, X Chen, JJ Smith, MK Washington, KE Hill, ... Cancer research 73 (3), 1245-1255, 2013	207	2013
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma LH Lee, MS Cavalcanti, NH Segal, JF Hechtman, MR Weiser, JJ Smith, ... Modern Pathology 29 (11), 1433-1442, 2016	199	2016
Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells AB Singh, A Sharma, JJ Smith, M Krishnan, X Chen, S Eschrich, ... Gastroenterology 141 (6), 2140-2153, 2011	192	2011
Mismatch repair–deficient rectal cancer and resistance to neoadjuvant chemotherapy A Cercek, G Dos Santos Fernandes, CS Roxburgh, K Ganesh, S Ng, ... Clinical Cancer Research 26 (13), 3271-3279, 2020	189	2020
Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation P Dhawan, R Ahmad, R Chaturvedi, JJ Smith, R Midha, MK Mittal, ... Oncogene 30 (29), 3234-3247, 2011	187	2011
International consensus recommendations on key outcome measures for organ preservation after (chemo) radiotherapy in patients with rectal cancer E Fokas, A Appelt, R Glynne-Jones, G Beets, R Perez, J Garcia-Aguilar, ... Nature Reviews Clinical Oncology 18 (12), 805-816, 2021	171	2021

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy